---
title: Eyecare Among the Top Selling Medicines of Pharma 2024
description: Two ophthalmic drugs, Eyelea and Vabysmo, top pharma sales in 2024, leading the market for retinal disease treatments.
---

[Vision Executives Blog](https://visionexecutives.com/blog)

# [Eyecare Among the Top Selling Medicines of Pharma 2024](https://visionexecutives.com/blog/eyecare-among-the-top-selling-medicines-of-pharma-2024)

 Written by [Vision Executives](https://visionexecutives.com/blog/author/vision-executives) | May 13, 2025 2:48:26 PM

[#𝐄𝐲𝐞𝐜𝐚𝐫𝐞](https://www.linkedin.com/search/results/all/?keywords=%23eyecare&origin=HASH_TAG_FROM_FEED) 𝐀𝐦𝐨𝐧𝐠 𝐭𝐡𝐞 𝐓𝐡𝐞 𝐓𝐨𝐩 𝐒𝐞𝐥𝐥𝐢𝐧𝐠 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐨𝐟 𝐏𝐡𝐚𝐫𝐦𝐚 2024

💪 Great to see 2 [#ophthalmic](https://www.linkedin.com/search/results/all/?keywords=%23ophthalmic&origin=HASH_TAG_FROM_FEED) drugs made the list of top selling medicines for 2024 including Bayer with Eyelea and Roche Vabysmo.

👁 [Bayer](https://www.linkedin.com/company/bayer/)  
Bayer, alongside [Regeneron](https://www.linkedin.com/company/regeneron-pharmaceuticals/), co-markets Eyelea – a leading anti-VEGF therapy for age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion. While not listed as their top seller, Eylea continues to dominate the retina market globally.

👁 [Roche](https://www.linkedin.com/company/roche/)  
Vabysmo (faricimab)—a bispecific antibody targeting both VEGF and Ang-2—has been a game-changer in retinal disease. Launched as a challenger to Eylea, it has gained strong traction thanks to its dual-action and potential for extended dosing.

👁 While [Novartis](https://www.linkedin.com/company/novartis/)—with Lucentis, a competitor to Eylea—and [AbbVie](https://www.linkedin.com/company/abbvie/) both have ophthalmic drugs in their pipelines, neither company saw them break into their top three bestsellers this year.

Graphic: Joanna Sadowska

[View full post](https://visionexecutives.com/blog/eyecare-among-the-top-selling-medicines-of-pharma-2024)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Vision Executives"
  },
  "dateModified" : "2025-05-13T14:48:26.527Z",
  "datePublished" : "2025-05-13T14:48:26Z",
  "headline" : "Eyecare Among the Top Selling Medicines of Pharma 2024",
  "image" : {
    "@type" : "ImageObject",
    "height" : 1080,
    "url" : "https://139544819.fs1.hubspotusercontent-eu1.net/hubfs/139544819/Pharma%20Giants%202024.png",
    "width" : 1080
  },
  "mainEntityOfPage" : "https://visionexecutives.com/blog/eyecare-among-the-top-selling-medicines-of-pharma-2024",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Vision Executives Blog"
  }
}
```